Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Diabetes

Free Subscription 14.10.2019 2 Biochem Biophys Res Commun 3 BMJ 1 Circ Genom Precis Med 5 Circulation 3 Diabetes 6 Diabetes Care 4 Diabetes Obes Metab 1 Diabetologia 1 Eur J Endocrinol 1 J Am Soc Nephrol 1 J Biol Chem 3 J Clin Endocrinol Metab 1 J Nutr 1 JAMA 1 Lancet Diabetes Endocrinol 1 Obstet Gynecol 4 Pediatr Diabetes 1 PLoS Med 6 PLoS One 1 Retina

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Biochem Biophys Res Commun

1. ZHAO H, Tao S
   MiRNA-221 protects islet beta cell function in gestational diabetes mellitus by targeting PAK1.
   Biochem Biophys Res Commun. 2019 Oct 3. pii: S0006-291X(19)31877.
   PubMed     Text format     Abstract available
   
   
2. WANG K, Liu D, Zhang Y, Chang X, et al
   SAD-A, a downstream mediator of GLP-1 signaling, promotes the phosphorylation of Bad S155 to regulate in vitro beta-cell functions.
   Biochem Biophys Res Commun. 2019;509:76-81.
   PubMed     Text format     Abstract available
   
   

   
   BMJ

3. IACOBUCCI G
   Thousands more patients with type 1 diabetes are getting flash glucose devices, data show.
   BMJ. 2019;367:l5895.
   PubMed     Text format    
   
   
4. HOOPER L, Brown T, Brainard J, Abdelhamid A, et al
   Authors' reply to Henderson.
   BMJ. 2019;366:l5703.
   PubMed     Text format    
   
   
5. 
   Quality of dietary fat and genetic risk of type 2 diabetes: individual participant data meta-analysis.
   BMJ. 2019;367:l5612.
   PubMed     Text format    
   
   

   
   Circ Genom Precis Med

6. KETTUNEN J, Ritchie SC, Anufrieva O, Lyytikainen LP, et al
   Biomarker Glycoprotein Acetyls Is Associated With the Risk of a Wide Spectrum of Incident Diseases and Stratifies Mortality Risk in Angiography Patients.
   Circ Genom Precis Med. 2018;11:e002234.
   PubMed     Text format     Abstract available
   
   

   
   Circulation

7. MADIAS JE
   Letter by Madias Regarding Article, "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".
   Circulation. 2018;138:1176-1177.
   PubMed     Text format    
   
   
8. GODOY LC, Rao V, Farkouh ME
   Coronary Revascularization of Patients With Diabetes Mellitus in the Setting of Acute Coronary Syndromes.
   Circulation. 2019;140:1233-1235.
   PubMed     Text format    
   
   
9. INZUCCHI SE, Kosiborod M, Fitchett D, Wanner C, et al
   Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control.
   Circulation. 2018;138:1904-1907.
   PubMed     Text format    
   
   
10. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
    Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
    Circulation. 2018;138:1819-1827.
    PubMed     Text format     Abstract available
    
    
11. CHAPMAN AR, Mills NL
    Response To Letter Regarding Article "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".
    Circulation. 2018;138:1178.
    PubMed     Text format    
    
    

    
    Diabetes

12. CHEN ZZ, Liu J, Morningstar J, Heckman-Stoddard BM, et al
    Metabolite Profiles of Incident Diabetes and Heterogeneity of Treatment Effect in the Diabetes Prevention Program.
    Diabetes. 2019 Oct 3. pii: db19-0236. doi: 10.2337/db19-0236.
    PubMed     Text format     Abstract available
    
    
13. BERGMAN RN, Piccinini F, Kabir M, Kolka CM, et al
    Erratum. Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes 2019;68:1709-1716.
    Diabetes. 2019 Oct 9. pii: db19-er12a. doi: 10.2337.
    PubMed     Text format    
    
    
14. KUSMARTSEVA I, Beery M, Hiller H, Padilla M, et al
    Temporal Analysis of Amylase Expression in Control, Autoantibody Positive, and Type 1 Diabetes Pancreatic Tissues.
    Diabetes. 2019 Oct 9. pii: db19-0554. doi: 10.2337/db19-0554.
    PubMed     Text format     Abstract available
    
    

    
    Diabetes Care

15. CRITCHLEY JA, Carey IM, Harris T, DeWilde S, et al
    Variability in Glycated Hemoglobin and Risk of Poor Outcomes Among People With Type 2 Diabetes in a Large Primary Care Cohort Study.
    Diabetes Care. 2019 Oct 3. pii: dc19-0848. doi: 10.2337/dc19-0848.
    PubMed     Text format     Abstract available
    
    
16. POTIER L, Roussel R, Marre M, Bjornstad P, et al
    Plasma Copeptin and Risk of Lower-Extremity Amputation in Type 1 and Type 2 Diabetes.
    Diabetes Care. 2019 Oct 3. pii: dc19-1062. doi: 10.2337/dc19-1062.
    PubMed     Text format     Abstract available
    
    
17. DROUIN-CHARTIER JP, Zheng Y, Li Y, Malik V, et al
    Changes in Consumption of Sugary Beverages and Artificially Sweetened Beverages and Subsequent Risk of Type 2 Diabetes: Results From Three Large Prospective U.S. Cohorts of Women and Men.
    Diabetes Care. 2019 Oct 3. pii: dc19-0734. doi: 10.2337/dc19-0734.
    PubMed     Text format     Abstract available
    
    
18. CEPERUELO-MALLAFRE V, Llaurado G, Keiran N, Benaiges E, et al
    Erratum. Preoperative Circulating Succinate Levels as a Biomarker for Diabetes Remission After Bariatric Surgery. Diabetes Care 2019;42:1956-1965.
    Diabetes Care. 2019 Oct 9. pii: dc19-er12a. doi: 10.2337.
    PubMed     Text format    
    
    
19. VAISAR T, Kanter JE, Wimberger J, Irwin AD, et al
    High Concentration of Medium-Sized HDL Particles and Enrichment in HDL Paraoxonase 1 Associate With Protection From Vascular Complications in People With Long-standing Type 1 Diabetes.
    Diabetes Care. 2019 Oct 9. pii: dc19-0772. doi: 10.2337/dc19-0772.
    PubMed     Text format     Abstract available
    
    
20. DAS L, Bhansali A, Prakash M, Jude EB, et al
    Effect of Methylprednisolone or Zoledronic Acid on Resolution of Active Charcot Neuroarthropathy in Diabetes: A Randomized, Double-Blind, Placebo-Controlled Study.
    Diabetes Care. 2019 Oct 9. pii: dc19-1659. doi: 10.2337/dc19-1659.
    PubMed     Text format    
    
    

    
    Diabetes Obes Metab

21. DOUROS A, Dell'Aniello S, Yu OHY, Suissa S, et al
    Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study.
    Diabetes Obes Metab. 2019 Oct 9. doi: 10.1111/dom.13893.
    PubMed     Text format     Abstract available
    
    
22. ABERER F, Pferschy PN, Tripolt NJ, Sourij C, et al
    Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.
    Diabetes Obes Metab. 2019 Oct 8. doi: 10.1111/dom.13889.
    PubMed     Text format     Abstract available
    
    
23. DING Y, Zhu X, Li X, Chen H, et al
    Pharmacokinetics and pharmacodynamics of rongliflozin, a novel selective inhibitor of sodium-glucose co-transporter-2, in people with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2019 Oct 6. doi: 10.1111/dom.13887.
    PubMed     Text format     Abstract available
    
    
24. GHOUSE J, Isaksen JL, Skov MW, Lind B, et al
    Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Diabetes Obes Metab. 2019 Oct 9. doi: 10.1111/dom.13891.
    PubMed     Text format     Abstract available
    
    

    
    Diabetologia

25. AHOLA-OLLI AV, Mustelin L, Kalimeri M, Kettunen J, et al
    Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts.
    Diabetologia. 2019 Oct 4. pii: 10.1007/s00125-019-05001.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Endocrinol

26. NAUCK MA, Meier JJ
    MANAGEMENT OF ENDOCRINE DISEASE: Are all GLP-1 agonist equal in the treatment of type 2 diabetes?
    Eur J Endocrinol. 2019 Oct 1. pii: EJE-19-0566.R1. doi: 10.1530/EJE-19-0566.
    PubMed     Text format     Abstract available
    
    

    
    J Am Soc Nephrol

27. LEMLEY KV
    Machine Learning Comes to Nephrology.
    J Am Soc Nephrol. 2019;30:1780-1781.
    PubMed     Text format    
    
    

    
    J Biol Chem

28. OHNO RI, Ichimaru K, Tanaka S, Sugawa H, et al
    Glucoselysine is derived from fructose and accumulates in the eye lens of diabetic rats.
    J Biol Chem. 2019 Oct 8. pii: RA119.010744. doi: 10.1074/jbc.RA119.010744.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Endocrinol Metab

29. ANDRADE VFC, Chula DC, Sabbag FP, Cavalheiro DDDS, et al
    BONE HISTOMORPHOMETRY IN YOUNG PATIENTS WITH TYPE 2 DIABETES IS AFFECTED BY DISEASE CONTROL AND CHRONIC COMPLICATIONS.
    J Clin Endocrinol Metab. 2019 Oct 7. pii: 5582037. doi: 10.1210.
    PubMed     Text format     Abstract available
    
    
30. LEE AK, Woodward M, Wang D, Ohkuma T, et al
    The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
    J Clin Endocrinol Metab. 2019 Oct 7. pii: 5582233. doi: 10.1210.
    PubMed     Text format     Abstract available
    
    
31. GABORIT B, Julla JB, Besbes S, Proust M, et al
    Glucagon-like peptide 1 receptor agonists, diabetic retinopathy and angiogenesis: The AngioSafe type 2 diabetes study.
    J Clin Endocrinol Metab. 2019 Oct 7. pii: 5582609. doi: 10.1210.
    PubMed     Text format     Abstract available
    
    

    
    J Nutr

32. FERNANDEZ ML
    Small HDL Particles Are Associated with Gestational Diabetes, Providing a Potential Early Identification Tool.
    J Nutr. 2019 Oct 4. pii: 5580872. doi: 10.1093.
    PubMed     Text format    
    
    

    
    JAMA

33. NOTLEY SR, Poirier MP, Sigal RJ, D'Souza A, et al
    Exercise Heat Stress in Patients With and Without Type 2 Diabetes.
    JAMA. 2019;322:1409-1411.
    PubMed     Text format    
    
    

    
    Lancet Diabetes Endocrinol

34. TAYLOR SI, Blau JE, Rother KI, Beitelshees AL, et al
    SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks.
    Lancet Diabetes Endocrinol. 2019 Oct 1. pii: S2213-8587(19)30154.
    PubMed     Text format     Abstract available
    
    

    
    Obstet Gynecol

35. ASHIMI BALOGUN O, Sibai BM, Pedroza C, Blackwell SC, et al
    Serial Third-Trimester Ultrasonography Compared With Routine Care in Uncomplicated Pregnancies: A Randomized Controlled Trial.
    Obstet Gynecol. 2018 Nov 5. doi: 10.1097/AOG.0000000000002970.
    PubMed     Text format     Abstract available
    
    

    
    Pediatr Diabetes

36. RAMIREZ-MENDOZA F, Gonzalez JE, Gasca E, Camacho M, et al
    Time in range and HbA1C after 6 months with a multidisciplinary program for children and adolescents with Diabetes Mellitus, real world data from Mexico City.
    Pediatr Diabetes. 2019 Oct 4. doi: 10.1111/pedi.12921.
    PubMed     Text format     Abstract available
    
    
37. SLAVCHEVA-PRODANOVA O, Konstantinova M, Tsakova A, Savova R, et al
    Bone Health Index and Bone Turnover in Pediatric Patients with Type 1 Diabetes Mellitus and Poor Metabolic Control.
    Pediatr Diabetes. 2019 Oct 9. doi: 10.1111/pedi.12930.
    PubMed     Text format     Abstract available
    
    
38. KANE NS, Hoogendoorn CJ, Commissariat PV, Schulder TE, et al
    Glycemic Control and Self-Rated Health Among Ethnically Diverse Adolescents with Type 1 Diabetes.
    Pediatr Diabetes. 2019 Oct 7. doi: 10.1111/pedi.12928.
    PubMed     Text format     Abstract available
    
    
39. CORREYA TA, Ashraf AP, Griffin R, Aslibekyan S, et al
    Temporal Trends in Incidence of Pediatric Type 1 Diabetes in Alabama: 2000-2017.
    Pediatr Diabetes. 2019 Oct 7. doi: 10.1111/pedi.12927.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

40. WHYTE MB, Hinton W, McGovern A, van Vlymen J, et al
    Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    PLoS Med. 2019;16:e1002942.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

41. WAHABI H, Fayed A, Tunkar SMS, Bakhsh H, et al
    Incidence and contributing factors of glucose intolerance in Saudi postpartum women: Sub-group analysis from RAHMA study.
    PLoS One. 2019;14:e0210024.
    PubMed     Text format     Abstract available
    
    
42. HORII T, Momo K, Yasu T, Kabeya Y, et al
    Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan.
    PLoS One. 2019;14:e0223431.
    PubMed     Text format     Abstract available
    
    
43. KRAEGE V, Vollenweider P, Waeber G, Sharp SJ, et al
    Development and multi-cohort validation of a clinical score for predicting type 2 diabetes mellitus.
    PLoS One. 2019;14:e0218933.
    PubMed     Text format     Abstract available
    
    
44. KISHI K, Kaji N, Kurosawa T, Aikiyo S, et al
    Hyperglycemia in the early stages of type 1 diabetes accelerates gastric emptying through increased networks of interstitial cells of Cajal.
    PLoS One. 2019;14:e0222961.
    PubMed     Text format     Abstract available
    
    
45. DE GAETANO A, Hardy TA
    A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program.
    PLoS One. 2019;14:e0222833.
    PubMed     Text format     Abstract available
    
    
46. YUZEFOVYCH LV, Pastukh VM, Ruchko MV, Simmons JD, et al
    Plasma mitochondrial DNA is elevated in obese type 2 diabetes mellitus patients and correlates positively with insulin resistance.
    PLoS One. 2019;14:e0222278.
    PubMed     Text format     Abstract available
    
    

    
    Retina

47. ZHU TP, Li EH, Li JY, Dai XZ, et al
    COMPARISON OF PROJECTION-RESOLVED OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY-BASED METRICS FOR THE EARLY DETECTION OF RETINAL MICROVASCULAR IMPAIRMENTS IN DIABETES MELLITUS.
    Retina. 2019 Oct 1. doi: 10.1097/IAE.0000000000002655.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: